Top Markets
#1 Black Phoenix Black Phoenix +828.57%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.40%
#3 Beam Beam +23.21%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +22.56%
#5 SAFEcoin SAFEcoin +20.80%
#6 Magma Finance Magma Finance +20.11%
#7 pipedog pipedog +18.82%
#8 Bless Bless +16.88%
#9 PondCoin PondCoin +16.70%
#10 THORChain THORChain +16.34%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rank in Stocks #6153
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Share Price
$156.13
Market Cap
$2.24B
Change (1 day)
1.17%
Change (1 year)
176.58%
Country
US
Trade Palvella Therapeutics, Inc. (PVLA)

Category

Healthcare
Stock price history for Palvella Therapeutics, Inc. (PVLA)
Highest end of day price: $151.80 on 2026-08-01

Lowest end of day price: $13.11 on 2024-12-01
Stock price history of Palvella Therapeutics, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 7.49%
2025 649.84%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.88 41.07%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.71%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.94 461.51%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH